Selection of elderly acute myeloid leukemia patients for intensive chemotherapy: Effectiveness of intensive chemotherapy and subgroup analysis

Dae Sik Kim, Ka Won Kang, Eun Sang Yu, Hong Jun Kim, Jung Sun Kim, Se Ryeon Lee, Yong Park, Hwa Jung Sung, Soo Young Yoon, Chul Won Choi, Byung Soo Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Despite the advances in acute myeloid leukemia (AML) treatment, the prognosis of elderly patients remains poor and no definitive treatment guideline has been established. In the present study, we aimed to evaluate the effectiveness of intensive chemotherapy in elderly AML patients and to determine which subgroup of patients would be most responsive to the therapy. Methods: We retrospectively analyzed 84 elderly patients: 35, 19, and 30 patients were administered intensive chemotherapy, low-dose chemotherapy, and supportive care, respectively. Results: Among those who received intensive chemotherapy, there were 17 cases of remission after induction chemotherapy; treatment-related mortality was 22.9%. The median overall survival was 7.9 months. Multivariate analysis indicated that the significant prognostic factors for overall survival were performance status, fever before treatment, platelet count, blast count, cytogenetic risk category, and intensive chemotherapy. Subgroup analysis showed that intensive chemotherapy was markedly effective in the relatively younger patients (65-70 years) and those with de novo AML, better-to-intermediate cytogenetic risk, no fever before treatment, high albumin levels, and high lactate dehydrogenase levels. Conclusions: Elderly AML patients had better outcomes with intensive chemotherapy than with low-intensity chemotherapy. Thus, appropriate subgroup selection for intensive chemotherapy is likely to improve therapeutic outcome.

Original languageEnglish
Pages (from-to)300-309
Number of pages10
JournalActa Haematologica
Volume133
Issue number3
DOIs
Publication statusPublished - 2015 Apr 25

Keywords

  • Acute myeloid leukemia
  • Aging
  • Intensive chemotherapy

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Selection of elderly acute myeloid leukemia patients for intensive chemotherapy: Effectiveness of intensive chemotherapy and subgroup analysis'. Together they form a unique fingerprint.

Cite this